<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Siga Technologies Inc — News on 6ix</title>
<link>https://6ix.com/company/siga-technologies-inc</link>
<description>Latest news and press releases for Siga Technologies Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Thu, 30 Apr 2026 11:30:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/siga-technologies-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835c14d78dffbe2df118d8e.webp</url>
<title>Siga Technologies Inc</title>
<link>https://6ix.com/company/siga-technologies-inc</link>
</image>
<item>
<title>SIGA to Host Business Update Call on May 7, 2026, Following Release of First-Quarter 2026 Financial Results</title>
<link>https://6ix.com/company/siga-technologies-inc/news/siga-to-host-business-update-call-on-may-7-2026-following-release-of-first-quarter-2026-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/siga-technologies-inc/news/siga-to-host-business-update-call-on-may-7-2026-following-release-of-first-quarter-2026-financial-results</guid>
<pubDate>Thu, 30 Apr 2026 11:30:00 GMT</pubDate>
<description>NEW YORK, April 30, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Thursday, May 7, 2026. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer. A live webcast of the call will also be available on the Company's website at http://www.siga.com in th</description>
</item>
<item>
<title>SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2025 and Provides Business Update</title>
<link>https://6ix.com/company/siga-technologies-inc/news/siga-reports-financial-results-for-three-and-twelve-months-ended-december-31-2025-and-provides-business-update-11</link>
<guid isPermaLink="true">https://6ix.com/company/siga-technologies-inc/news/siga-reports-financial-results-for-three-and-twelve-months-ended-december-31-2025-and-provides-business-update-11</guid>
<pubDate>Tue, 10 Mar 2026 04:00:00 GMT</pubDate>
<description>Generated TPOXX Product Revenues of $88 Million in 2025 Received $13 Million International Procurement Order for Oral TPOXX in January 2026 Corporate Update</description>
</item>
<item>
<title>SIGA to Host Business Update Call on March 10, 2026, Following Release of 2025 Financial Results</title>
<link>https://6ix.com/company/siga-technologies-inc/news/siga-to-host-business-update-call-on-march-10-2026-following-release-of-2025-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/siga-technologies-inc/news/siga-to-host-business-update-call-on-march-10-2026-following-release-of-2025-financial-results</guid>
<pubDate>Tue, 03 Mar 2026 12:30:00 GMT</pubDate>
<description>NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Tuesday, March 10, 2026. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer. A live webcast of the call will also be available on the Company's website at http://www.siga.com in</description>
</item>
<item>
<title>SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2025</title>
<link>https://6ix.com/company/siga-technologies-inc/news/siga-reports-financial-results-three-and-nine-months-ended-september-30-2025-2025-11</link>
<guid isPermaLink="true">https://6ix.com/company/siga-technologies-inc/news/siga-reports-financial-results-three-and-nine-months-ended-september-30-2025-2025-11</guid>
<pubDate>Thu, 06 Nov 2025 05:00:00 GMT</pubDate>
<description>Corporate Update Conference Call Today at 4:30 PM ET NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a</description>
</item>
<item>
<title>SIGA to Host Business Update Call on November 6, 2025 Following Release of Third-Quarter 2025 Results</title>
<link>https://6ix.com/company/siga-technologies-inc/news/siga-host-business-update-call-november-6-2025-following-release-third-quarter-2025</link>
<guid isPermaLink="true">https://6ix.com/company/siga-technologies-inc/news/siga-host-business-update-call-november-6-2025-following-release-third-quarter-2025</guid>
<pubDate>Thu, 30 Oct 2025 04:00:00 GMT</pubDate>
<description>NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that</description>
</item>
<item>
<title>SIGA Reports Financial Results for Three and Six Months Ended June 30, 2025</title>
<link>https://6ix.com/company/siga-technologies-inc/news/siga-reports-financial-results-three-and-six-months-ended-june-30-2025-2025-08-06</link>
<guid isPermaLink="true">https://6ix.com/company/siga-technologies-inc/news/siga-reports-financial-results-three-and-six-months-ended-june-30-2025-2025-08-06</guid>
<pubDate>Tue, 05 Aug 2025 04:00:00 GMT</pubDate>
<description>NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Generated Product Revenues of $79 million for the Three Months Ended June 30Awarded Additional Development Funding</description>
</item>
<item>
<title>SIGA to Host Business Update Call on August 5, 2025 Following Release of Second-Quarter 2025 Results</title>
<link>https://6ix.com/company/siga-technologies-inc/news/siga-host-business-update-call-august-5-2025-following-release-second-quarter-2025</link>
<guid isPermaLink="true">https://6ix.com/company/siga-technologies-inc/news/siga-host-business-update-call-august-5-2025-following-release-second-quarter-2025</guid>
<pubDate>Tue, 29 Jul 2025 04:00:00 GMT</pubDate>
<description>NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that</description>
</item>
<item>
<title>SIGA Reports Financial Results for Three Months Ended March 31, 2025</title>
<link>https://6ix.com/company/siga-technologies-inc/news/siga-reports-financial-results-three-months-ended-march-31-2025-2025-05-08</link>
<guid isPermaLink="true">https://6ix.com/company/siga-technologies-inc/news/siga-reports-financial-results-three-months-ended-march-31-2025-2025-05-08</guid>
<pubDate>Thu, 08 May 2025 04:00:00 GMT</pubDate>
<description>Received $26 Million IV TPOXX Procurement Order from the U.S. Government in March$94 million in TPOXX Orders (to be Delivered to U.S. Strategic National</description>
</item>
<item>
<title>SIGA to Host Business Update Call on May 8, 2025 Following Release of First-Quarter 2025 Results</title>
<link>https://6ix.com/company/siga-technologies-inc/news/siga-host-business-update-call-may-8-2025-following-release-first-quarter-2025</link>
<guid isPermaLink="true">https://6ix.com/company/siga-technologies-inc/news/siga-host-business-update-call-may-8-2025-following-release-first-quarter-2025</guid>
<pubDate>Thu, 01 May 2025 04:00:00 GMT</pubDate>
<description>NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that</description>
</item>
<item>
<title>SIGA Declares Special Cash Dividend of $0.60 Per Share</title>
<link>https://6ix.com/company/siga-technologies-inc/news/siga-declares-special-cash-dividend-060-share-2025-04-08</link>
<guid isPermaLink="true">https://6ix.com/company/siga-technologies-inc/news/siga-declares-special-cash-dividend-060-share-2025-04-08</guid>
<pubDate>Tue, 08 Apr 2025 04:00:00 GMT</pubDate>
<description>NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that</description>
</item>
<item>
<title>SIGA Appoints Retired General John M. Keane to its Board of Directors</title>
<link>https://6ix.com/company/siga-technologies-inc/news/siga-appoints-retired-general-john-m-keane-its-board-directors-2025-03-18</link>
<guid isPermaLink="true">https://6ix.com/company/siga-technologies-inc/news/siga-appoints-retired-general-john-m-keane-its-board-directors-2025-03-18</guid>
<pubDate>Tue, 18 Mar 2025 04:00:00 GMT</pubDate>
<description>General Keane brings significant expertise in national security and biodefense preparedness NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies,</description>
</item>
<item>
<title>SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2024</title>
<link>https://6ix.com/company/siga-technologies-inc/news/siga-reports-financial-results-three-and-twelve-months-ended-december-31-2024-2025-03</link>
<guid isPermaLink="true">https://6ix.com/company/siga-technologies-inc/news/siga-reports-financial-results-three-and-twelve-months-ended-december-31-2024-2025-03</guid>
<pubDate>Tue, 11 Mar 2025 04:00:00 GMT</pubDate>
<description>Increased Product Sales to $133 Million in 2024Generated Pre-tax Operating Income and Net Income of $70 Million and $59 Million, Respectively, in</description>
</item>
<item>
<title>SIGA to Host Business Update Call on March 11, 2025 Following Release of Fourth-Quarter and Full Year 2024 Financial Results</title>
<link>https://6ix.com/company/siga-technologies-inc/news/siga-host-business-update-call-march-11-2025-following-release-fourth-quarter-and</link>
<guid isPermaLink="true">https://6ix.com/company/siga-technologies-inc/news/siga-host-business-update-call-march-11-2025-following-release-fourth-quarter-and</guid>
<pubDate>Tue, 04 Mar 2025 05:00:00 GMT</pubDate>
<description>NEW YORK, March 04, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that</description>
</item>
<item>
<title>TEPOXX (tecovirimat) Approved in Japan for the Treatment of Orthopoxviruses</title>
<link>https://6ix.com/company/siga-technologies-inc/news/tepoxx-tecovirimat-approved-japan-treatment-orthopoxviruses-2025-01-02</link>
<guid isPermaLink="true">https://6ix.com/company/siga-technologies-inc/news/tepoxx-tecovirimat-approved-japan-treatment-orthopoxviruses-2025-01-02</guid>
<pubDate>Thu, 02 Jan 2025 05:00:00 GMT</pubDate>
<description>Regulatory decision marks first approval in Japan of an antiviral for the treatment of orthopoxviruses including smallpox, mpox and cowpoxJapan Biotechno</description>
</item>
<item>
<title>Interim Results from STOMP Study of SIGA’s Tecovirimat in Treatment of Mpox Announced</title>
<link>https://6ix.com/company/siga-technologies-inc/news/interim-results-stomp-study-sigas-tecovirimat-treatment-mpox-announced-2024-12-10</link>
<guid isPermaLink="true">https://6ix.com/company/siga-technologies-inc/news/interim-results-stomp-study-sigas-tecovirimat-treatment-mpox-announced-2024-12-10</guid>
<pubDate>Tue, 10 Dec 2024 05:00:00 GMT</pubDate>
<description>Interim analysis shows that tecovirimat did not improve time to lesion resolution compared to placebo in adults with mild to moderate clade II mpoxStudy</description>
</item>
<item>
<title>SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2024</title>
<link>https://6ix.com/company/siga-technologies-inc/news/siga-reports-financial-results-three-and-nine-months-ended-september-30-2024-2024-11</link>
<guid isPermaLink="true">https://6ix.com/company/siga-technologies-inc/news/siga-reports-financial-results-three-and-nine-months-ended-september-30-2024-2024-11</guid>
<pubDate>Thu, 07 Nov 2024 05:00:00 GMT</pubDate>
<description>Product Revenues for the Three and Nine months Ended September 30, 2024 were $9 million and $53 million, respectivelyReceived $122 Million of Procurement</description>
</item>
<item>
<title>SIGA to Host Business Update Call on November 7 Following Release of Third-Quarter 2024 Financial Results</title>
<link>https://6ix.com/company/siga-technologies-inc/news/siga-host-business-update-call-november-7-following-release-third-quarter-2024</link>
<guid isPermaLink="true">https://6ix.com/company/siga-technologies-inc/news/siga-host-business-update-call-november-7-following-release-third-quarter-2024</guid>
<pubDate>Thu, 31 Oct 2024 04:00:00 GMT</pubDate>
<description>NEW YORK, Oct. 31, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that</description>
</item>
<item>
<title>SIGA Enters into Exclusive License Agreement with Vanderbilt University for Novel Poxvirus Monoclonal Antibodies</title>
<link>https://6ix.com/company/siga-technologies-inc/news/siga-enters-exclusive-license-agreement-vanderbilt-university-novel-poxvirus</link>
<guid isPermaLink="true">https://6ix.com/company/siga-technologies-inc/news/siga-enters-exclusive-license-agreement-vanderbilt-university-novel-poxvirus</guid>
<pubDate>Tue, 22 Oct 2024 04:00:00 GMT</pubDate>
<description>NEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company and leader in infectious</description>
</item>
<item>
<title>SIGA Announces Agreement to Supply TPOXX® in Morocco</title>
<link>https://6ix.com/company/siga-technologies-inc/news/siga-announces-agreement-supply-tpoxxr-morocco-2024-10-08</link>
<guid isPermaLink="true">https://6ix.com/company/siga-technologies-inc/news/siga-announces-agreement-supply-tpoxxr-morocco-2024-10-08</guid>
<pubDate>Tue, 08 Oct 2024 04:00:00 GMT</pubDate>
<description>NEW YORK, Oct. 08, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company and leader in infectious</description>
</item>
<item>
<title>SIGA Announces New Contract Awarded by U.S. Department of Defense for the Procurement of $9 Million of TPOXX®</title>
<link>https://6ix.com/company/siga-technologies-inc/news/siga-announces-new-contract-awarded-us-department-defense-procurement-9-million</link>
<guid isPermaLink="true">https://6ix.com/company/siga-technologies-inc/news/siga-announces-new-contract-awarded-us-department-defense-procurement-9-million</guid>
<pubDate>Wed, 21 Aug 2024 04:00:00 GMT</pubDate>
<description>NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company and leader in infectious</description>
</item>
</channel>
</rss>